The biotechnology company reported $0.01 EPS for the quarter ... This trade represents a 0.07 % increase in their ownership of the stock. The transaction was disclosed in a filing with the ...

Q2 2025 Management View CEO Steve Brass announced Q2 net sales of $146.1 million, a 5% increase from the prior fiscal year quarter. Adjusted for foreign currency impacts, net sales would have been ...

Analysts at Leerink Partnrs upped their FY2025 earnings estimates for shares of AxoGen in a research note issued to investors ...

EPS rose to $5.07, surpassing estimates of $4.63. Revenue reached $45.3 billion, beating expected $44 billion. Net income increased to $14.6 billion, up 9.2% from the prior year. JPMorgan Chase ...

Fiscal 2024 adjusted EPS grew 15% to $10.05, while first quarter fiscal 2025 adjusted EPS increased 14% to $2.75. Visa boasts a strong surprise history with beating earnings estimates in each of ...

Diluted GAAP earnings per share (EPS) grew by 3% to $3.76, and adjusted diluted EPS increased by 1.4% to $4.28. FactSet updated its fiscal 2025 guidance, forecasting organic ASV growth of $100 ...

TD Synnex ( SNX) shares sank 17% Thursday when the distributor of IT products posted worse-than-expected results and guidance ...